Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum Covalon Technologies Ltd V.COV

Alternate Symbol(s):  CVALF

Covalon Technologies Ltd. is a Canada-based patient-driven medical device company that provides healthcare solutions for advanced wound care, infection control, and medical device coatings. The Company's solutions are designed for patients and made for care providers. The Company leverages its patented medical technology platforms and expertise in two ways: by developing products that are sold... see more

Bullboard (TSXV:COV)

View:
User Avatar Image
(4)
•••
  • FactualOneX
Post by FactualOneon May 25, 2023 8:07am

Covalon Announces Second Quarter Financial Results FY2023

https://ir.covalon.com/news-and-events/news/news-details/2023/Covalon-Announces-Second-Quarter-Results-for-Fiscal-2023/default.aspx
User Avatar Image
(4)
•••
  • FactualOneX
Post by FactualOneon May 23, 2023 11:20am

Covalon Q2 Earnings Date and Conference Call Details

https://ir.covalon.com/news-and-events/news/news-details/2023/Covalon-Announces-Conference-Call-to-Discuss-Second-Quarter-Fiscal-2023-Financial-Results/default.aspx
User Avatar Image
(9)
•••
  • bronkrdrX
Post by bronkrdron May 15, 2023 10:51am

Dec 22 quarter financial.

Had a great 1/4 with $6.1 M in revenue and steady expenses. Looking forward for the next 1/4. we're almost in the black.
User Avatar Image
(1767)
•••
  • Possibleidiot01X
Post by Possibleidiot01on Apr 30, 2023 9:08pm

Planet MicroCap presentation - April 26, 2023

https://www.webcaster4.com/Player/Index?webcastId=47976&g=52e6919d-91f3-4f4f-bded-deec8d6f0ce1&uid=6251359&sid=
User Avatar Image
(9)
•••
  • bronkrdrX
Post by bronkrdron Feb 24, 2023 5:01pm

4th Quarter Financials

A 25% increase in sales and a very low variable cost increase has my attention. Pleased to say I like this investment.
Comment by ARIMA11on Feb 23, 2023 9:55am

RE:RE:RE:RE:4Q & Yearend fiscal '22

Good quarter but concerns are still present. i. Zero analyst questions... This is rather odd. Something to be improved. ii. https://ceo.ca/@newswire/covalon-announces-expansion-of-its-united-states ...more  
User Avatar Image
(4)
•••
  • FactualOneX
Post by FactualOneon Feb 20, 2023 1:30pm

Covalon @ Neonatology Conference in LV Feb 22-24

https://www.newswire.ca/news-releases/infection-prevention-solutions-provider-covalon-to-participate-for-the-first-time-in-neo-the-conference-for-neonatology-in-las-vegas-nv-on-february-22-24-2023 ...more  
User Avatar Image
(4)
•••
  • FactualOneX
Post by FactualOneon Feb 20, 2023 1:29pm

Covalon Announces Conference Call to Discuss Q1 Results

https://www.newswire.ca/news-releases/covalon-announces-conference-call-to-discuss-first-quarter-fiscal-2023-financial-results-812551832.html
Comment by ARIMA11on Jan 26, 2023 8:51pm

RE:RE:RE:4Q & Yearend fiscal '22

Unfortunate that they did not provide an update on the total number of US Children Hospitals . https://ceo.ca/@newswire/covalon-announces-expansion-of-its-united-states-pediatric (Sept 2022 ...more  
Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities